ECE2015 Eposter Presentations Diabetes (pathiophysiology & epitemiology) (80 abstracts)
The clinical effectiveness of screening for gestational diabetes mellitus in primary vs secondary care: results of a randomised controlled trial
Angela O’Dea 1 , Marie Tierney 1 , Liam Glynn 1 , Andrii Danyliv 1 , Louise Carmody 2 , Brian McGuire 1 , John Newell 1 , Eoin Noctor 1 & Fidelma Dunne 1
1National University of Ireland, Galway, Ireland; 2HSE, Galway, Ireland.
Aims: The aim of this paper is to report on the outcomes of a clinical trial investigating the clinical effectiveness of universal screening for gestational diabetes mellitus (GDM) in primary care vs secondary care.
Design and methods: A parallel group randomised controlled trial of universal screening for GDM in primary vs secondary care. The primary outcome – uptake of screening in primary vs secondary care is reported elsewhere. In this article we report on the secondary outcomes of the trial: i) GDM prevalence, ii) timing of screening, iii) time to access antenatal diabetes care, and iv) maternal and neonatal outcomes.
Results: The prevalence of GDM was similar in primary care and secondary care screening groups, and groups were comparable in terms of the timeliness of screening, with both groups receiving screening at a mean of ~26 weeks. However there was a considerable delay (in both groups) in the time to access hospital treatment for women with GDM. For patients screened in the hospital the delay is 19 days, for those screened at the GP the delay is 24 days. Further research is needed to understand the reasons for this delay. In addition the GP group had a higher proportion of large for gestational age infants than the hospital group. It is possible that the delay in access to care is implicated in the increased infant size in this group; further research on a larger sample will be needed to answer this question. There were no differences between groups in maternal outcomes.
Conclusions: The evidence presented in this paper, shows that the hospital is still the best option for GDM screening, in terms of access to screening and in terms of time to access hospital care for those with GDM. Implications for long term GDM care are discussed.
Disclosure: This work was funded by the Health Research Board of Ireland – Interdisciplinary Capacity Enhancement grant number: ICE/2011/3.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more